4.9.8.1Vertical

Compounding Pharmacies

Pharmacies preparing custom medications for specific patient needs.

Market snapshot

These figures describe Retail & Specialty Pharmacy (4.9.8), the segment that Compounding Pharmacies sits within. They are not figures for Compounding Pharmacies on its own.

Market size
~$544B
Growth
~4.4%CAGR (2017–22, nominal)
Companies
~18,857 firms
FragmentationConsolidatedEstimate

A consolidated but margin-stressed channel in which CVS, Walgreens, and Walmart dominate ~18,900 firms, with store closures mounting under PBM reimbursement pressure. The ~$544B is largely drug pass-through, not retail value-add; specialty pharmacy (high-cost complex drugs) is the high-growth piece, and Amazon Pharmacy, Cost Plus, and mail order are reshaping distribution. Growth is proxied from the broader health-and-personal-care retail series, since the 2022 recode breaks the pharmacy-specific time series.

NAICS 456110 (2017 basis: 446110). U.S. Census Bureau, 2022 Economic Census (revenue) and 2022 Statistics of U.S. Businesses (firms); growth proxied from U.S. Census Bureau, Monthly Retail Trade Survey (MARTS), health & personal care stores (category 446).

Business model & economics

Revenue model

Drug-dispensing revenue (largely pass-through) plus front-of-store

Key economics

Recurring revenue
High

recurring prescription refills

EBITDA margin
Thin dispensing margins, PBM-squeezed
Capex intensity
Moderate

Characteristics

  • Consolidated but financially stressed retail channel.
  • Specialty pharmacy the high-growth piece.
  • New entrants reshaping distribution; thin PBM-squeezed margins.

M&A deal context

Deal activityModerate

Who’s acquiring

  • Pharmacy chains & strategics
  • Specialty-pharmacy consolidators
  • Mail-order & new-entrant platforms

What’s driving deals

  • Specialty-pharmacy growth and acquisition.
  • Channel disruption from mail order and new entrants.
  • Reimbursement pressure and store rationalization.

Find Compounding Pharmacies acquisition targets

Search Acquisera’s index for companies classified under Compounding Pharmacies (4.9.8.1) and build a targeted deal pipeline.

Search companies